H. N. Abramson, “The Multiple Myeloma Drug Pipeline-2018: A Review of Small Molecules and Their Therapeutic Targets in sentence style,” Clin Lymphoma Myeloma Leuk title, vol.18, no.9, pp. 611-627, 2018.
 P. L. Bergsagel, W. M. Kuehl, “Chromosome translocations in multiple myeloma in sentence style,” Oncogene title, vol.20, no.40, pp. 5611-5622, 2001.
 J. De Vos, T. Thykjaer, K. Tarte, M. Ensslen, P. Raynaud, G. Requirand et al, “Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays in sentence style,” Oncogene title, vol.21, no.44, pp. 6848-6857, 2002.
 F. Cottini, T. Hideshima, C. Xu, M. Sattler, M. Dori, L. Agnelli et al, “Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers in sentence style,” Nat Med title, vol.20, no.6, pp. 599-606, 2014.
 D. K. Walters, X. Wu, R. C. Tschumper, B. K. Arendt, P. M. Huddleston, K. J. Henderson et al, “Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX in sentence style,” Leukemia title, vol.25, no.8, pp. 1344-1353, 2011.
 L. Mazzera, M. Abeltino, G. Lombardi, A. M. Cantoni, R. Ria, M. Ricca et al, “Functional interplay between NF-kappaB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma in sentence style,” Haematologica title, vol.104, no.12, pp. 2465-2481, 2019.
 S. Gao, C. Geng, T. Song, X. Lin, J. Liu, Z. Cai et al, “Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase in sentence style,” J Biol Chem title, vol.292, no.9, pp. 3683-3691, 2017.
 J. Mei, Y. Zhai, H. Li, F. Li, X. Zhou, P. Song et al, “Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China in sentence style,” J Cancer Res Clin Oncol title, vol.144, no.11, pp. 2263-2273, 2018.
 S. Van Wier, E. Braggio, A. Baker, G. Ahmann, J. Levy, J. D. Carpten et al, “Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma in sentence style,” Haematologica title, vol.98, no.10, pp. 1586-1592, 2013.
 T. G. Lugo, O. N. Witte, “The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc in sentence style,” Mol Cell Biol title, vol.9, no.3, pp. 1263-1270, 1989.
 J. Lin, R. Arlinghaus, “Activated c-Abl tyrosine kinase in malignant solid tumors in sentence style,” Oncogene title, vol.27, no.32, pp. 4385-4391, 2008.
 D. Srinivasan, R. Plattner, “Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells in sentence style,” Cancer Res title, vol.66, no.11, pp. 5648-5655, 2006.
 A. Pandiella, X. Carvajal-Vergara, S. Tabera, G. Mateo, N. Gutierrez, J. F. San Miguel, “Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents in sentence style,” British journal of haematology title, vol.123, no.5, pp. 858-868, 2003.
 P. Vigneri, J. Y. Wang, “Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase in sentence style,” Nature medicine title, vol.7, no.2, pp. 228-234, 2001.
 S. Kosztolanyi, R. Kiss, L. Atanesyan, A. Gango, K. de Groot, M. Steenkamer et al, “High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma in sentence style,” J Mol Diagn title, vol.20, no.6, pp. 777-788, 2018.
 S. Doi, Y. Tashiro, N. Yoshinaga, W. Kishimoto, T. Hamada, C. Ueda et al, “[BCR-ABL1-positive myelodysplastic syndrome with neutropenia and anemia treated successfully with imatinib mesylate] in sentence style,” Rinsho Ketsueki title, vol.61, no.5, pp. 455-461, 2020.
 K. Miki, N. Obara, K. Makishima, T. Sakamoto, M. Kusakabe, T. Kato et al, “An Unprecedented Case of p190 BCR-ABL Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature in sentence style,” Case Rep Hematol title, vol.2018, no., pp. 7863943, 2018.
 T. Otto, P. Sicinski, “Cell cycle proteins as promising targets in cancer therapy in sentence style,” Nature reviews Cancer title, vol.17, no.2, pp. 93-115, 2017.
 J. Colicelli, “ABL tyrosine kinases: evolution of function, regulation, and specificity in sentence style,” Sci Signal title, vol.3, no.139, pp. re6, 2010.
 H. Huang, W. Guo, L. He et al, “Evidence for ABL Amplification in Multiple Myeloma and Its Role in Treatment,” Research Square, DOI: 10.21203/rs.3.rs-48781/v1